1-Methanesulfonylazetidin-3-ol

Catalog No. :
ACVXJC136
CAS No. :
1344068-80-9
Molecular Formula :
C4H9NO3S
Molecular Weight :
151.19

IUPAC Name:1-(methylsulfonyl)azetidin-3-ol

1-Methanesulfonylazetidin-3-ol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$279.00Login to see priceInquiryInquiry
250mg95%$370.00Login to see priceInquiryInquiry
500mg95%$618.00Login to see priceInquiryInquiry
1g95%$926.00Login to see priceInquiryInquiry
5g95%$2781.00Login to see priceInquiryInquiry
10g95%$4244.00Login to see priceInquiryInquiry
25g95%$8487.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-Methanesulfonylazetidin-3-ol
IUPAC Name1-(methylsulfonyl)azetidin-3-ol
MDL No.MFCD18267456
Molecular FormulaC4H9NO3S
Molecular Weight151.19
SMILESOC1CN(S(=O)(C)=O)C1
InChI KeyCPTYCCCFVMZEDY-UHFFFAOYSA-N
Synonym1-METHANESULFONYLAZETIDIN-3-OL | 1344068-80-9 | 1-methylsulfonylazetidin-3-ol | SCHEMBL12017936 | MFCD18267456 | AKOS012406660 | PB28748 | AS-51281 | CS-0052483 | P12305 | EN300-1707535
CAS No.1344068-80-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACVXJC136 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACICXL305 route compound structure diagram
    ACICXL30518621-18-6 In Stock
  4. Then
  5. ACVXJC136 route product structure diagram
    ACVXJC1361344068-80-9
Inquiry

2. ACVXJC136 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVXJC136 route product structure diagram
    ACVXJC1361344068-80-9
Inquiry

Comments (0)